Theriva Biologics, Inc. (TOVX)
0.25
0.00 (0.00%)
USD |
NYAM |
Aug 31, 16:00
0.2514
0.00 (0.00%)
After-Hours: 20:00
Theriva Biologics Cash from Operations (TTM) : -12.74M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -12.74M |
| March 31, 2026 | -14.37M |
| December 31, 2025 | -16.67M |
| September 30, 2025 | -18.48M |
| June 30, 2025 | -18.07M |
| March 31, 2025 | -16.81M |
| December 31, 2024 | -16.94M |
| September 30, 2024 | -18.79M |
| June 30, 2024 | -17.83M |
| March 31, 2024 | -18.27M |
| December 31, 2023 | -19.00M |
| September 30, 2023 | -17.82M |
| June 30, 2023 | -19.33M |
| March 31, 2023 | -19.79M |
| December 31, 2022 | -19.08M |
| September 30, 2022 | -18.52M |
| June 30, 2022 | -16.22M |
| March 31, 2022 | -14.46M |
| December 31, 2021 | -12.89M |
| September 30, 2021 | -11.21M |
| June 30, 2021 | -11.11M |
| March 31, 2021 | -10.54M |
| December 31, 2020 | -12.17M |
| September 30, 2020 | -12.64M |
| June 30, 2020 | -13.65M |
| Date | Value |
|---|---|
| March 31, 2020 | -14.61M |
| December 31, 2019 | -13.87M |
| September 30, 2019 | -13.56M |
| June 30, 2019 | -14.10M |
| March 31, 2019 | -15.42M |
| December 31, 2018 | -17.28M |
| September 30, 2018 | -17.92M |
| June 30, 2018 | -18.84M |
| March 31, 2018 | -20.28M |
| December 31, 2017 | -20.20M |
| September 30, 2017 | -26.66M |
| June 30, 2017 | -28.12M |
| March 31, 2017 | -28.24M |
| December 31, 2016 | -27.90M |
| September 30, 2016 | -28.49M |
| June 30, 2016 | -37.72M |
| March 31, 2016 | -39.11M |
| December 31, 2015 | -38.89M |
| September 30, 2015 | -32.70M |
| June 30, 2015 | -22.02M |
| March 31, 2015 | -18.07M |
| December 31, 2014 | -16.08M |
| September 30, 2014 | -14.00M |
| June 30, 2014 | -11.19M |
| March 31, 2014 | -9.527M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 185.56M |
| Nkarta, Inc. | -92.76M |
| Unicycive Therapeutics, Inc. | -27.84M |
| OnKure Therapeutics, Inc. | -47.84M |
| ACADIA Pharmaceuticals, Inc. | 160.32M |